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Previous inhibition studies with taurocholate and cardiac glycosides suggested
the presence of separate uptake systems for small “type I” (system1) and for bulky
“type II” (system2) organic cations in rat hepatocytes. To identify the transport
systems involved in type I and type II organic cation uptake, we compared the
organic cation transport properties of the rat and human organic cation transporter 1
(rOCT1; hOCT1) and of the organic anion transporting polypeptides 2 and A (rat
Oatp2; human OATP-A) in cRNA-injected Xenopus laevis oocytes. Based on
characteristic cis-inhibition patterns of rOCT1-mediated tributylmethylammonium and
Oatp2-mediated rocuronium uptake, rOCT1 and Oatp2 could be identified as the
organic cation uptake systems1 and 2, respectively, in rat liver. While hOCT1
exhibited similar transport properties as rOCT1, OATP-A- but not Oatp2-mediated
rocuronium uptake was inhibited by the OATP-A substrate N-methyl-quinidine. The
latter substrate was also transported by rOCT1 and hOCT1, demonstrating distinct
organic cation transport activities for rOCT1 and Oatp2 and overlapping organic
cation transport activities for hOCT1 and OATP-A. Finally, the data demonstrate that
unmethylated quinidine is transported by rOCT1, hOCT1, and OATP-A at pH 6.0, but
not at pH 7.5, indicating that quinidine requires a positive charge for carrier-mediated
uptake into hepatocytes. In conclusion, the studies demonstrate that in rat liver the
suggested organic cation uptake systems1 and 2 correspond to rOCT1 and Oatp2,
respectively. However, the rat based type I and II organic cation transporter
classification cannot be extended without modification from rat to man.
INTRODUCTION
Hepatic clearance of organic cations is a major pathway of xenobiotic
elimination from the systemic circulation. It has been estimated that at least 50 % of
the presently available therapeutic agents have a (partly) cationic character
(Groothuis and Meijer, 1996). The positive charge is either due to quaternary
ammonium groups in the molecule or to tertiary amine groups, which are protonated
to a large extent at physiological pH (Meijer et al., 1990). In isolated rat hepatocytes
and in isolated perfused rat liver, two uptake systems for organic cations have been
proposed (Steen et al., 1992; Groothuis and Meijer, 1996). Uptake system1
transports relatively small “type I” organic cations such as tetraethylammonium (TEA)
(Moseley et al., 1992), tributylmethylammonium (TBuMA) (Steen et al., 1991; 1992;
Moseley et al., 1996), procainamide ethobromide (PAEB) and its azido analogue
azidoprocainamide methoiodide (APM) (Mol et al., 1992). Uptake system2 transports
more bulky “type II” organic cations, including d-tubocurarine, metocurine as well as
the steroidal muscle relaxants vecuronium (Mol et al., 1988) and rocuronium (ORG
9426) (Steen et al., 1992; Proost et al., 1997). While the rat liver organic cation
uptake system1 can be inhibited by type II organic cations, it is not sensitive to
cardiac glycosides and taurocholate (Steen et al., 1992; Oude Elferink et al., 1995).
In contrast, the rat liver organic cation uptake system2 is insensitive to type I
substrates, but it is inhibited by cardiac glycosides and taurocholate (Steen et al.,
1992; Oude Elferink et al., 1995). Hence, uptake system2 seems to represent a
multispecific organic solute uptake system that recognizes bulky amphipathic
compounds independent of their charge (Groothuis and Meijer, 1996).
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Rat hepatocytes express the organic cation transporter 1 (rOCT1; gene
symbol Slc22a1) (Grundemann et al., 1994; Meyer-Wentrup et al., 1998) and the
organic anion transporting polypeptide 2 (Oatp2; Slc21a5) (Reichel et al., 1999) at
their blood faced basolateral (sinusoidal) plasma membrane domain. rOCT1
mediates charge-selective transport of relatively water-soluble small organic cations
such as TEA, 1-methyl-4-phenylpyridinium, and choline (Koepsell, 1998) and, thus,
could qualify for the organic cation uptake system1 in rat liver. Oatp2 exhibits a wide
substrate preference and can mediate uptake of anionic bile salts, uncharged cardiac
glycosides (e.g. digoxin) and type II organic cations such as N-(4,4-azo-n-pentyl)-21-
deoxyajmalinium (APDA) and rocuronium (Reichel et al., 1999; van Montfoort et al.,
1999), indicating that Oatp2 might represent the multispecific organic cation uptake
system2 in rat liver (van Montfoort et al., 1999).
The goals of the current study were 2-fold: 1) to definitely investigate the
suggested correspondence of the rat liver organic cation uptake systems1 and 2 with
rOCT1 and Oatp2, respectively, using the same model compounds as originally used
to establish the type I and II classification of organic cations (Steen et al., 1992); and
2) to compare the organic cation transport specificities of the rOCT1 and Oatp2 with
the human transporters hOCT1 (SLC22A1) and OATP-A (previously called OATP;
SLC21A3), the latter having the broadest transport activity for type II organic cations
of all Oatps/OATPs so far characterized (van Montfoort et al., 1999; Kullak-Ublick et
al., 2001). The results support the hypothesis that rOCT1 corresponds to the organic
cation uptake system1 and Oatp2 to the organic cation uptake system2 in rat liver.
Some cationic drugs such as APDA can be transported both by Oatp2 and rOCT1,
indicating at least some overlapping substrate specificity between the two families of
membrane transporters. The data also demonstrate differences in the substrate
preferences between rat (rOCT1; Oatp2) and human (hOCT1; OATP-A) carriers,
indicating that the type I and II classification can not be extended without modification
from rat to man.
EXPERIMENTAL PROCEDURES
Materials
[14C]Tetraethylammonium (TEA; 5 mCi/mmol) was obtained from PerkinElmer
Life Science Products (Boston, MA). [3H]Quinidine (QD; 20 Ci/mmol) was purchased
from American Radiolabeled Chemicals (St. Louis, MO). [14C]Rocuronium (54
mCi/mmol) and unlabeled rocuronium were kind gifts of Organon International BV
(Oss, The Netherlands). N-(4,4-azo-n-pentyl)-21-deoxy[21-3H]ajmalinium (APD-
ajmalinium, APDA; 1.2 Ci/mmol), N-(4,4-azo-n-pentyl)-quinuclidine (APQ; 2.5
Ci/mmol), and unlabeled APQ were synthesized as described (Müller et al., 1994).
[3H]Tributylmethylammonium (TBuMA; 85 Ci/mmol) was synthesized according to
Neef et al. (1984). Unlabeled TBuMA was obtained from Fluka (Buchs, Switzerland).
[3H]N-methyl-quinine (NMQ; 85 Ci/mmol) and [3H]N-methyl-quinidine (NMQD; 85
Ci/mmol) were synthesized and characterized as described (van Montfoort et al.,
1999). [3H]Azidoprocainamide methoiodide (APM; 85 Ci/mmol) and unlabeled APM
were synthesized according to Mol et al. (1992). Radiochemical purity of the not
commercially available substrates was determined by thin-layer chromatography and
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exceeded 99%. All other chemicals were of analytical grade and readily available
from commercial sources.
Uptake studies in Xenopus laevis oocytes
rOCT1 cDNA was subcloned into the pRSSP vector (Busch et al., 1996) and
linearized with Mlu I. hOCT1 cDNA was subcloned into the pOG1 vector (Gorboulev
et al., 1997) and linearized with Not I. cRNA was synthesized with the Ambion
mMessage mMachine In Vitro Transcription Kit using SP6 RNA polymerase for
rOCT1 and T7 RNA polymerase for hOCT1 (Ambion, Austin, TX). In vitro synthesis of
Oatp2- and OATP-A-cRNA was performed as described (Kullak Ublick et al., 1995;
Noe et al., 1997). X. laevis oocytes were prepared (Hagenbuch et al., 1996) and
cultured overnight at 18°C. Healthy oocytes were microinjected with 50 nl water
without and with 10 ng of rOCT1-, 10 ng of hOCT1-, 5 ng of Oatp2-, or 2.5 ng of
OATP-A-cRNA and cultured for 3 days in a medium containing 88 mM NaCl, 2.4 mM
NaHCO3, 1 mM KCl, 0.3 mM Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 0.05
mg/ml gentamycin, and 15 mM HEPES (pH 7.6). Tracer uptake studies were
performed in a NaCl-containing uptake medium (100 mM NaCl, 2 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, and 10 mM HEPES-Tris, pH 7.5 or 10 mM 4-morpholino-
ethanesulfonic acid-Tris, pH 6.0). The oocytes were washed in the uptake medium
and then incubated at 25 °C in 100 µl of the uptake medium containing the indicated
substrate concentrations. Water-injected oocytes were used as controls for
unspecific uptake of the substrate. After the indicated time intervals, uptake was
stopped by addition of 6 ml ice-cold uptake medium. The oocytes were washed twice
with 6 ml ice-cold uptake medium. Subsequently, each oocyte was dissolved in 0.25
ml of 10% SDS and 4 ml of scintillation fluid (Ultima Gold; Canberra Packard, Zürich,
Switzerland) and the oocyte-associated radioactivity determined in a Tri-Carb 2200
CA liquid scintillation analyzer (Canberra Packard). Determination of kinetic uptake
parameters was performed by a nonlinear curve fitting program (Systat 8.0; SPSS
Inc., Chicago, IL) using a simple Michaelis-Menten model v = (Vmax·[S])/(Km+[S]).
Statistical analysis
Uptake results are given as means ± S.D. Statistical significance of transport
differences between the various oocyte groups was determined by the Student’s t
test (Systat 8.0, SPSS Inc., Chicago, IL).
RESULTS
To identify rOCT1 as the type I organic cation uptake system (system1) and
Oatp2 as the type II organic cation uptake system (system2) of rat liver, we first
performed a series of cis-inhibition studies in rOCT1- and Oatp2-expressing X. laevis
oocytes using TBuMA as a type I and rocuronium as a type II substrate. As illustrated
in Fig. 1A, rOCT1-mediated TBuMA uptake was inhibited by APM (a type I
compound) and rocuronium (a type II compound), but not by taurocholate, ouabain,
and K-strophantoside. This cis-inhibition pattern is characteristic for the rat liver
organic cation uptake system1 (Steen et al., 1992), which therefore corresponds to
rOCT1. The latter was also inhibited by QD as previously described (Koepsell et al.,
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Figure 1. cis-Inhibition pattern of TBuMA and rocuronium uptake mediated by rOCT1 (A) and Oatp2
(B), respectively. X. laevis oocytes were injected with 10 ng of rOCT1 or 5 ng of Oatp2 cRNA. After 3
days in culture, uptakes of [3H]-TBuMA (35 µM) by rOCT1 (A) and of [14C]-rocuronium (25 µM) by
Oatp2 (B) were measured at 30 min (under Experimental Procedures) in the absence (control) and
presence of the indicated compounds (all 200 µM, except ouabain 2 mM). Uptake rates of water-
injected oocytes were subtracted from cRNA-injected oocytes for each substrate. Data are expressed
as means ± S.D. of uptake measurements into 10 oocytes. *, significant uptake inhibition (Student’s t
test, p < 0.01) compared with controls.
1999) as well as by its methylated derivative NMQD (Fig.1A). In contrast, Oatp2-
mediated rocuronium uptake was insensitive to the type I compounds TBuMA and
APM, but was strongly inhibited by taurocholate, ouabain and K-strophantoside (Fig.
1B). This cis-inhibition pattern is characteristic for the rat liver organic cation uptake
system2 (Steen et al., 1992), which therefore corresponds to Oatp2. No significant
inhibition of Oatp2-mediated rocuronium uptake was found for QD and NMQD (Fig.
1B), which is consistent with the previous observation that NMQD is not transported
by Oatp2 (van Montfoort et al., 1999).
Next we evaluated whether the characteristic cis-inhibition pattern of rOCT1






























































































Figure 2. cis-Inhibition pattern of TBuMA and rocuronium uptake mediated by hOCT1 (A) and OATP-
A (B), respectively. X. laevis oocytes were injected with 10 ng of hOCT1 or 2.5 ng of OATP-A cRNA.
After 3 days in culture, uptakes of [3H]-TBuMA (35 µM) by hOCT1 (A) and of [14C]-rocuronium (25 µM)
by OATP-A (B) were measured at 30 min (under Experimental Procedures) in the absence (control)
and presence of the indicated compounds (all 200 µM, except ouabain 2 mM). Uptake rates of water-
injected oocytes were subtracted from cRNA-injected oocytes for each substrate. Data are expressed
as means ± S.D. of uptake measurements into 10 oocytes. *, significant uptake inhibition (Student’s t
test, p < 0.01) as compared with controls.
illustrated in Fig. 2A, hOCT1-mediated TBuMA uptake showed qualitatively a similar
cis-inhibition pattern as rOCT1-mediated TBuMA uptake (Fig. 1A), indicating that
hOCT1 and rOCT1 represent orthologous gene products with similar type I organic
cation transport properties in rat and human liver. In contrast, OATP-A-mediated
rocuronium uptake was inhibited by APM, taurocholate, K-strophantoside, QD, and
NMQD, but not by TBuMA and ouabain (Fig. 2B). This cis-inhibition pattern is clearly
different compared to Oatp2 (Fig. 1B). While part of these differences can be
explained by distinct transport activities [e.g., NMQD is a transport substrate of
OATP-A, but not of Oatp2 (van Montfoort et al., 1999)] and/or substrate affinities
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Figure 3. Comparison of rOCT1- and hOCT1-mediated uptake of [3H]NMQ, [3H]NMQD, [3H]APDA,
[14C]rocuronium, [3H]TBuMA, [3H]APM and [3H]APQ. X. laevis oocytes were injected with 10 ng of
rOCT1 (A) or 10 ng of hOCT1 cRNA (B). After 3 days in culture, uptakes of the indicated substrates
were measured at 2 µM (except rocuronium at 14 µM) for 30 min in Na+ buffer (under Experimental
Procedures). The standard substrate TEA was used as positive control to test the expression of
rOCT1 and hOCT1 in the cRNA-injected oocytes. The uptake rates of the water-injected control
oocytes were subtracted from the cRNA-injected oocytes for each substrate. Data represent the mean
± S.D. from 11 to 15 oocyte uptake measurements. *, significantly different from water-injected control
oocytes (Student’s t test, p < 0.001).
et al., 1996; Noe et al., 1997)] of OATP-A and Oatp2, the inhibitory effect of the type I
organic cation APM on OATP-A-mediated rocuronium uptake is surprising since APM
has been shown to be not transported by OATP-A (van Montfoort et al., 1999).
Hence, the data indicate that the rat based classification of type I and type II organic
cations and its association with distinct organic cation carriers cannot be applied to
the human situation without modification.
Based on their physicochemical properties as permanently charged bulky
quaternary ammonium compounds it has been suggested that NMQ and NMQD














































































overall structure of these compounds shows a spatial separation of the single
cationic group (surrounded by aliphatic moieties as in TBuMA and PAEB) from an
aromatic structure as has been considered as being typical for type I compounds
(Meijer et al., 1990; Groothuis and Meijer, 1996). Even APDA exhibits these
structural features to some extent. The latter consideration is supported by the
findings that NMQD inhibits rOCT1- and hOCT1-mediated TBuMA uptake rather than
Oatp2-mediated rocuronium uptake (Figs. 1 and 2). Therefore, we tested next
organic cation transport in rOCT1- and hOCT1-expressing oocytes. As illustrated in
Fig. 3, and consistent with the cis-inhibition data, rOCT1 and hOCT1 mediated not
only transport of the type I compounds TBuMA, APM, and APQ but also of the
previously supposed type II substrates NMQ, NMQD and also but to a lesser extent,
ADPA. The only type II organic cation not significantly transported by rOCT1 and
hOCT1 was rocuronium.
Time course experiments showed linear uptake rates for NMQ, NMQD,
TBuMA, and APM for at least 30 min (data not shown). Therefore, kinetic uptake
measurements were performed at 15 min. They showed saturation kinetics as
indicated in Fig. 4 for hOCT1. Similar kinetic features were also obtained for rOCT1
with all apparent Km values given in Table 1. These data confirm the affinity of rOCT1
and hOCT1 for the established type I organic cations TBuMA, APM and APQ.
However, since rOCT1 and hOCT1 also transport the rather bulky organic cations
NMQ, NMQD, and APDA, the data indicate that this physicochemical property alone
should not be used to predict the types of carrier involved in hepatic organic cation
uptake. In this study, only rocuronium showed entirely the expected behaviour as a
type II organic cation, i.e., exclusive and taurocholate/cardiac glycoside inhibitable
transport by Oatp2 and OATP-A, respectively. Other examples of type II compounds
are d-tubocurarine, metocurine, hexafluronium and vecuronium. A general feature of
these agents is that a) the cationic groups are not clearly separated from the
aromatic moieties or other bulky ring structures and b) that they contain a second
quaternary or tertiary amine structure and consequently can form bivalent cationic
molecules.
The quaternary ammonium compounds used in this study are permanently
positively charged model compounds and with the exception of rocuronium not used
as drugs. Therefore we also investigated transport of the drug quinidine, which is a
tertiary amine and shown to inhibit rOCT1, hOCT1 and OATP-A (Figs. 1 and 2)
Quinidine is a base with a pKa of 8.5 (Notterman et al., 1986) which means that at pH
7.5 about 10% of the quinidine molecules are protonated, while at pH 6.0 almost all
molecules are positively charged. It can be seen in Fig. 5 that there is no significant
quinidine transport by OATP-A-, rOCT1- or hOCT1-cRNA injected X. laevis oocytes
at pH 7.5. At pH 6.0, however, transport of quinidine becomes detectable since the
unspecific uptake into water injected oocytes is markedly reduced. These findings
suggest that quinidine molecules need a positive charge to be transported by OATP-
A, rOCT1, and hOCT1. In the unprotonated form, quinidine most probably enters the
oocytes by passive diffusion as can be seen by the large unspecific uptake into
water-injected oocytes at pH 7.5 (Fig. 5).
DISCUSSION
The present study identifies rOCT1 as the type I organic cation uptake system
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Figure 4. Saturation kinetics of NMQ, NMQD, TBuMA and APM in hOCT1-cRNA injected X. laevis
oocytes. X. laevis oocytes were injected with 10 ng of hOCT1-cRNA. After 3 days in culture, uptakes
of [3H]NMQ (A), [3H]NMQD (B), [3H]TBuMA (C) and [3H]APM (D) were measured at 15 min in Na+
buffer (under Experimental Procedures) containing increasing substrate concentrations. The dotted
lines represent fitted uptake differences between hOCT1-cRNA (λ) and water-injected oocytes (Ο).
Data are expressed as mean ± S.D. of 10 to 12 oocyte uptake measurements.
(system1) and Oatp2 as the type 2 organic cation uptake system (system2) in rat
liver. This conclusion is based on the typical cis-inhibition of rOCT1-mediated TBuMA
uptake by type I and type II cations, but not by taurocholate and cardiac glycosides
(Fig. 1A) (Steen et al., 1992), and of Oatp2-mediated rocuronium uptake by
taurocholate and cardiac glycosides, but not by type I cations (Fig. 1B) (Steen et al.,
1992). While the transport properties of hOCT1 were similar to rOCT1 (Fig. 2A), the
cis-inhibition patterns of Oatp2- and OATP-A-mediated rocuronium uptake were
different in part in that OATP-A, but not Oatp2, was inhibited by the type I organic
cation APM, QD and NMQD (Fig. 2B). Thus, the clear-cut associations between
transport of type I and type II organic cations by rOCT1 and Oatp2, respectively, is
not entirely valid for hOCT1 and OATP-A, which supports the concept that the human
OATP-A is not the orthologous gene product of the rat Oatp2 (Kullak-Ublick et al.,
2001). Furthermore, studies in isolated human hepatocytes showed that rocuronium
uptake could be inhibited by K-strophantoside and by the type I organic cation PAEB,
but not by taurocholate (Olinga et al., 1998). These findings are an additional
indication for species differences between organic cation uptake systems of rat and
human liver. Since none of the so far identified human hepatic OATPs [i.e., OATP-B
(SLC21A9), OATP-C (SLC21A6) and OATP8 (SLC2A8)] was able to transport
organic cations, a human orthologue of rat Oatp2 remains to be identified (Kullak-
Ublick et al., 2001). It might also be possible that the transport functions of rat and
N-methyl-quinine conc. [µM]















































































































Figure 5. pH dependence of OATP-A, rOCT1-, and hOCT1-mediated uptake of [3H]quinidine. X. laevis
oocytes were injected with 2.5 ng of OATP-A, 10 ng of rOCT1, or 10 ng of hOCT1 cRNA. After 3 days
in culture, uptake of quinidine was measured at 2 µM for 30 min in Na+ buffer at pH 7.5 (patterned
bars) or pH 6.0 (black bars) (under Experimental Procedures). NMQD was used as positive control to
test the expression of OATP-A, rOCT1 and hOCT1 in the cRNA-injected oocytes. Data represent the
mean ± S.D. from 10 oocyte uptake measurements. *, significantly different from water-injected control
oocytes (Student’s t test, p < 0.001).
human OATPs have evolved differently since in contrast to rat Oatp2 no human
OATP can transport both rocuronium and digoxin. In man, rocuronium is transported
by OATP-A (van Montfoort et al., 1999), while digoxin is transported by OATP8
(Kullak-Ublick et al., 2001).
The concept of rOCT1 corresponding to uptake system1 and Oatp2 to uptake
system2 is valid for the same substrates and inhibitors that were used originally in rat
hepatocytes (Steen et al., 1992). Other substrates have to be classified with caution.
NMQ, NMQD and APDA could, at first sight, be viewed upon as type II organic
cations because of their bulky structure (van Montfoort et al., 1999). According to the
proposed concept their uptake into rat liver is supposed to be mediated by Oatp2
rather than by rOCT1. However, while Oatp2 solely mediates the transport of the real
type II organic cation rocuronium, APDA is only to some extent accommodated by
OATP-A and Oatp2, respectively, whereas NMQ and NMQD even seem pure rOCT1-
mediated type I compounds (van Montfoort et al., 1999). Therefore, a positive charge
and a bulky structure alone are not sufficient to predict the putative uptake system.
As NMQ and NMQD are mainly taken up by rOCT1 which corresponds to uptake
system1, they should be reclassified as type I organic cations despite their bulky
structure. It is possible that rOCT1 and hOCT1 recognize a single cationic group
spatially separated from a flat (aromatic) ring structure that can be recognized in
APDA, NMQ, NMQD, and PAEB. The type I agents TBuMA and APQ also have a
single cationic group but lack an aromatic moiety. The only true type II substrate
used in this study that is consistently transported only by Oatps is the steroidal
muscle relaxant rocuronium. It shares a potential dicationic nature with previously
categorized type II compounds (Meijer et al., 1990) in combination with a sufficient
lipophilicity. The latter aspect and the presence of a permanently charged ammonium
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Table 1: Comparison of apparent Km values between OATP-A, rOCT1, and hOCT1. X. laevis oocytes
were injected with 2.5 ng of OATP-A-cRNA, 10 ng of rOCT1-cRNA, and 10 ng of hOCT1-cRNA. After
3 days in culture, uptakes of the indicated substrates were measured at 15 min in Na+ buffer under
Experimental Procedures containing increasing substrate concentrations. Data are expressed as





N-methyl-quinine  5.1 ± 2.1a 19.5 ± 7.3 17.3 ± 4.9
N-methyl-quinidine 25.6 ± 4.1a 11.5 ± 2.1  7.4 ± 2.1
TBuMA nt   53.0 ± 13.9 34.0 ± 7.7
APM nt  100.9 ± 43.0   54.0 ± 15.2
While there were considerable differences in the substrate specificity of Oatp2
and OATP-A in this study, rOCT1 and hOCT1 showed similar substrate specificities
and inhibition patterns (Figs. 1-3), although some quantitative differences were
observed in the inhibition of TBuMA by APM (rOCT1 > hOCT1) and NMQD (rOCT1 <
hOCT1). In addition, the apparent Km values for NMQ, NMQD, TBuMA, and APM
were comparable (Table 1). hOCT1 showed slightly higher Km values, which is in
agreement with previous findings where hOCT1 exhibited a lower affinity than rOCT1
for several other ligands (Koepsell et al., 1999). Furthermore, it has been shown that
hOCT1 transports larger n-tetraalkylammonium compounds such as
tetrapropylammonium and tetrabutylammonium at higher rates than rOCT1 (Dresser
et al., 2000). The kinetics of TBuMA and APM have also been determined in isolated
rat hepatocytes (Steen et al., 1991; Mol et al., 1992) where for both substrates the
presence of high- and low- affinity uptake systems has been suggested with apparent
Km values of ∼ 1.2 and ∼ 107 µM for TBuMA (Steen et al., 1991) and of ∼ 3 and ∼ 100
µM for APM, respectively (Mol et al., 1992). In the present study, rOCT1 showed
apparent Km values of 34 µM for TBuMA and of 54 µM for APM. If these values, as
obtained in the oocyte system, can be extrapolated to the hepatocyte, they could
correspond to the low-affinity system found in isolated rat hepatocytes. In that case,
candidate carriers for the supposed high affinity systems should be identified in the
future.
rOCT1, hOCT1, and OATP-A are not only inhibited by the permanently
positively charged NMQD, but also by the base quinidine (Figs. 1 and 2). However, at
pH 7.5 where only about 10% of the quinidine molecules are protonated no carrier-
mediated transport of quinidine could be detected (Fig. 5). In contrast, at pH 6.0,
where almost all quinidine molecules are positively charged, unspecific diffusion into
the oocytes was markedly reduced and uptake of the protonated quinidine by rOCT1,
hOCT1, and OATP-A became evident (Fig. 5). This finding is an indication that
quinidine is only transported by rOCT1, hOCT1, and OATP-A, when it carries a
positive charge. The mechanism of quinidine inhibition of rOCT1, hOCT1, and OATP-
A at pH 7.5 is not clear. It has been shown that quinine, which is a diastereomer of
quinidine, is a noncompetitive inhibitor of rOCT1 when added at the extracellular site,
suggesting an allosteric binding site (Koepsell, 1998). Recent experiments with
macropatches of rOCT2 cRNA-injected X. laevis oocytes in which quinine could also
be added from the cytoplasmic site showed competitive inhibition, suggesting that
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quinine inhibits rOCT2 from the intracellular site after crossing the lipid bilayer in its
uncharged form (Budimann et al., 2000)
In conclusion, the present study demonstrates that rOCT1 corresponds to the
predicted uptake system1 for type I organic cations in rat liver, whereas Oatp2
corresponds to uptake system2 for type II organic cations. However, the results
cannot be transferred to human liver without modifications. While the transport
properties of rOCT1 and hOCT1 are similar, considerable differences exist between
Oatp2 and OATP-A, indicating further that rat Oatps and human OATPs have
different transport properties and do not represent orthologous gene products.
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